Assistant Secretary of Preparedness and Response at the Department of Health and Human Services, Dawn O’Connell, said on a press call that the agency is in conversation with both Moderna and Pfizer about making avian influenza vaccines using messenger RNA-based technology.
Biotech firm’s and pharmaceutical giant’s stock prices rose today after it was revealed a number of these companies are in talks with the U.S. government to produce new vaccines to treat bird flu, as it is being reported that new cases in people are cropping up around the world.
Reportedly, a second farmworker in Michigan has contracted H5N1 avian flu after interacting with dairy cows. The first reported case of Highly-Pathogenic Avian Influenza (HPAI) in humans was reported back in March when a Texas farmworker purportedly contracted the virus. NBC’s Today reported:
‘On Wednesday, the U.S. Centers for Disease Control and Prevention confirmed a second human case of H5N1 in a farmworker on a dairy farm in Michigan. Cows on the farm had been infected, and the individual tested positive after an eye swab was sent to the CDC. The nasal swab turned up negative, indicating the patient had an eye infection, as only eye symptoms were reported.’
The CDC is still saying that the risk level of H5N1 in people is low. “Based on the information available, this infection does not change CDC’s current H5N1 bird flu human health risk assessment for the U.S. general public, which the agency considers to be low,” the CDC said in a press release.
In their press release, the CDC provided several current recommendations, which include:
- People should avoid close, long, or unprotected exposures to sick or dead animals, including wild birds, poultry, other domesticated birds, and other wild or domesticated animals (including cows)…
READ FULL ARTICLE HERE… (winepressnews.com)
Home | Caravan to Midnight (zutalk.com)
Be First to Comment